{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:37:29Z","timestamp":1772249849216,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    Kidney impairment is observed in patients with COVID-19. The effect of anti-COVID-19 agent remdesivir on kidneys is currently unknown. We aimed to determine the effect of remdesivir on renal fibrosis and its downstream mechanisms.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Remdesivir and its active nucleoside metabolite GS-441524 were used to treat TGF-\u03b2 stimulated renal fibroblasts (NRK-49F) and human renal epithelial (HK2) cells. Vehicle or remdesivir were given by intraperitoneal injection or renal injection through the left ureter in unilateral ureteral obstruction (UUO) mice. Serum and kidneys were harvested. The concentrations of remdesivir and GS-441524 were measured using LC-MS\/MS. Renal and liver function were assessed. Renal fibrosis was evaluated by Masson\u2019s trichrome staining and Western blotting.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Remdesivir and GS-441524 inhibited the expression of fibrotic markers (fibronectin and aSMA) in NRK-49F and HK2 cells. Intraperitoneal injection or renal injection of remdesivir attenuated renal fibrosis in UUO kidneys. Renal and liver function were unchanged in remdesivir treated UUO mice. Two remdesivir metabolites were detected after injection. Phosphorylation of Smad3 that was enhanced in cell and animal models for renal fibrosis was attenuated by remdesivir. In addition, the expression of Smad7, an anti-fibrotic factor, was increased after remdesivir treatment\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Moreover, knockdown of Smad7 blocked the antifibrotic effect of GS and RDV on renal cells.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Remdesivir inhibits renal fibrosis in obstructed kidneys.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2021.626510","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T07:13:04Z","timestamp":1625209984000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys"],"prefix":"10.3389","volume":"12","author":[{"given":"Lin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1681\/ASN.2020050589","article-title":"Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19","volume":"31","author":"Adamsick","year":"2020","journal-title":"Jasn"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e00221-18","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central Role of Dysregulation of TGF-\u03b2\/Smad in CKD Progression and Potential Targets of its Treatment","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.18.20023242","article-title":"Kidney Impairment Is Associated with In-Hospital Death of COVID-19 Patients","author":"Cheng","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.04.20031120","article-title":"Human Kidney Is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection","author":"Diao","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"gfw208","DOI":"10.1093\/ndt\/gfw208","article-title":"A Scoping Review of Adult Chronic Kidney Disease Clinical Pathways for Primary Care","volume":"32","author":"Elliott","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.12.20022418","article-title":"ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage after 2019-nCoV Infection","author":"Fan","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.kint.2016.08.025","article-title":"Progression of Chronic Kidney Disease: Too Much Cellular Talk Causes Damage","volume":"91","author":"Gewin","year":"2017","journal-title":"Kidney Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fphar.2017.00520","article-title":"Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype - Role of Risk Factors and Epigenetics","volume":"8","author":"Hewitson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"ii121","DOI":"10.1093\/ndt\/gfw330","article-title":"The Ascending Rank of Chronic Kidney Disease in the Global burden of Disease Study","volume":"32","author":"Jager","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse Roles of TGF-\u03b2\/Smads in Renal Fibrosis and Inflammation","volume":"7","author":"Lan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.08.20021212","article-title":"Caution on Kidney Dysfunctions of COVID-19 Patients","author":"Li","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal Tubule Injury: a Driving Force toward Chronic Kidney Disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biom9040141","article-title":"Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments","volume":"9","author":"Mart\u00ednez-Klimova","year":"2019","journal-title":"Biomolecules"},{"key":"B17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The Nucleoside Analog GS-441524 Strongly Inhibits Feline Infectious Peritonitis (FIP) Virus in Tissue Culture and Experimental Cat Infection Studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.arcmed.2020.05.001","article-title":"Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More","volume":"51","author":"Saha","year":"2020","journal-title":"Arch. Med. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum Antiviral GS-5734 Inhibits Both Epidemic and Zoonotic Coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative Therapeutic Efficacy of Remdesivir and Combination Lopinavir, Ritonavir, and Interferon Beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A Novel Coronavirus Outbreak of Global Health Concern","volume":"395","author":"Wang","year":"2020","journal-title":"The Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) In Vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and Multi-Organ Injuries in the Treatment of COVID-19","volume":"395","author":"Wang","year":"2020","journal-title":"The Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s11255-015-1115-9","article-title":"Role of Smad Signaling in Kidney Disease","volume":"47","author":"Zhang","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: a Retrospective Cohort Study","volume":"395","author":"Zhou","year":"2020","journal-title":"The Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"F1006","DOI":"10.1152\/ajprenal.00675.2009","article-title":"Mechanism of Chronic Aristolochic Acid Nephropathy: Role of Smad3","volume":"298","author":"Zhou","year":"2010","journal-title":"Am. J. Physiology-Renal Physiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.626510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T07:13:06Z","timestamp":1625209986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.626510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":28,"alternative-id":["10.3389\/fphar.2021.626510"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.626510","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.01.019943","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"article-number":"626510"}}